Skip to contentApplication 090620
- Type
- ANDA
- Sponsor
- ACTAVIS TOTOWA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TOPOTECAN HYDROCHLORIDE | TOPOTECAN HYDROCHLORIDE | INJECTABLE;INJECTION | EQ 4MG BASE/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 45963-615 | Topotecan hydrochloride | Topotecan hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
| 45963-615 | Topotecan hydrochloride | Topotecan hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
| 45963-615 | Topotecan hydrochloride | Topotecan hydrochloride | Actavis Pharma, Inc. | ANDA | Current |
| 45963-615 | Topotecan hydrochloride | Topotecan hydrochloride | Actavis Pharma, Inc. | ANDA | Current |